Tessa Therapeutics – Cancer Immunotherapy Treatments Tessa Therapeutics – Cancer Immunotherapy Treatments
  • menu
  • About Us
    • Our Story
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Strategic Partners
  • Science
    • Platform Technology
    • Our Approach
  • Pipeline
    • TT10 EBVSTs
    • TT11X Allogeneic CD30-CAR EBVSTs
    • TT12 Armored HPVSTs
    • TT16 HER2-CARTs + CAdVEC
    • TT18
  • Patients
  • Media
    • Press Releases
    • Feature News
    • Videos
  • Careers
  • Contact Us

  • All
  • Career Opportunities
  • home-featured
  • news-news
  • news-presentations
  • news-pressrelease
  • news-videos
  • Singapore – Regulatory CMC
  • US – Business Development
  • OUR COMPANY
  • OUR TECHNOLOGY
  • PIPELINE
  • PATIENTS
  • NEWS
  • CAREERS
  • CONTACT US
  • 特沙公司简介

FacebookLinkedinTwitterYoutube

SITEMAP          PRIVACY POLICY

© 2019 Tessa Therapeutics Ltd. All rights reserved.

  • About Us
    • Our Story
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Strategic Partners
  • Science
    • Platform Technology
    • Our Approach
  • Pipeline
    • TT10 EBVSTs
    • TT11X Allogeneic CD30-CAR EBVSTs
    • TT12 Armored HPVSTs
    • TT16 HER2-CARTs + CAdVEC
    • TT18
  • Patients
  • Media
    • Press Releases
    • Feature News
    • Videos
  • Careers
  • Contact Us